Skip to main content

Gate — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

1,203
Companies
$770.1M
Total invested
$8.3M
Avg. check
39
Industries
Biotechnology 11Health Care 8Medical 7Artificial Intelligence (AI) 6Therapeutics 4Life Science 3+33 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97–120 of 1,203
Coherence Neuro
November 2025

Coherence develops healthcare tech linking cancer neuroscience with neurotechnology for new treatments.

Health Care · Cambridge$10.0M Seed
AUI (Augmented Intelligence)
November 2025

AUI's Apollo-1 is a foundational model for conversational agents that function on behalf of entities, not users.

Artificial Intelligence (AI) · New York$20.0M Venture - Series Unknown
AltraTech
November 2025

Altratech Limited designs biosensors and semiconductor chips for DNA testing of food traceability for agri business.

Biotechnology · Shannon$441K Grant
HumanTruths
October 2025

HumanTruths is an AI platform that collects voice data from communities and analyzes it to provide insights.

Analytics · Belmont$684K Grant
Toragen
October 2025

Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.

Biotechnology · San DiegoGrant
PineTree Therapeutics
October 2025

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Biotechnology · Cambridge$47.0M Series B
MediMabBio
October 2025

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

Biotechnology · Seongnam$17.8M Series B
National Institute for Innovation in Manufacturing Biopharmaceuticals
October 2025

The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards.

Biotechnology · Newark$10.5M Grant
VitriVax
October 2025

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

Biotechnology · Boulder$17.3M Series B
APRO Oracle
October 2025

APRO Oracle is a decentralized oracle network developed exclusively for the Bitcoin environment.

Bitcoin · SingaporeSeed
Locstat
October 2025

Locstat is a Graph Analytics Platform providing graph intelligence capability and solutions in complex data environments.

Analytics · Cape Town$2.9M Seed
Magic
October 2025

Magic is an AI-based firm that merges personalization with experiences to bring real-world experiences.

Artificial Intelligence (AI) · New York$10.0M Seed
Magma Math
October 2025

Magma Math is an e-learning math platform for K–12 classrooms that helps improve teaching practises and learning for students.

E-Learning · Stockholm$10.0M Venture - Series Unknown
Counsel Health
October 2025

The modern front door to healthcare. AI meets real doctors for instant, personalized, and safe medical guidance—anytime, anywhere.

Artificial Intelligence (AI) · San Francisco$25.0M Series A
Monod Bio
October 2025

Monod Bio is a life sciences company developing biosensors for protein and other analyte detection.

Biotechnology · Seattle$750K Grant
BioMed X
October 2025

BioMed X is a research entrepreneurial and interdisciplinary environment at the interface between academia and industry.

Industrial · Heidelberg$2.0M Grant
hey circle
October 2025

Hey Circle is a manufacturer of reusable shipping packaging.

Recycling · MunichSeed
Lumen Bioscience
October 2025

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

Biopharma · Seattle$30.0M Series C
Octopus Deploy
October 2025

Accelerate software delivery with repeatable deployments.

Developer APIs · Brisbane$29.9M Venture - Series Unknown
NILO Therapeutics
October 2025

NILO Therapeutics is a biotechnology and therapeutics company.

Biotechnology · New York$101.0M Series A
Ladder Bio (formerly ThirdLaw Molecular)
October 2025

Ladder Bio is a therapeutics company that develops synthetic, ladder-shaped compounds engineered for high specificity and stability.

Biotechnology · Blue Bell$5.5M Seed
MOMM Diagnostics
October 2025

MOMM Diagnostics specializes in the development of an in-vitro diagnostic test for the early diagnosis of preeclampsia.

Health Care · Basel$500K Grant
Fleak
October 2025

Universal Schema Intelligence layer for machine communication

Artificial Intelligence (AI) · San Jose$5.0M Seed
Rapidemic
September 2025

Rapidemic is a developer of diagnostic kits for infectious diseases.

Biotechnology · Leiden$3.1M Grant

Where Gate invests

Biotechnology11
Health Care8
Medical7
Artificial Intelligence (AI)6
Therapeutics4
Life Science3

About Gate's portfolio

How many companies has Gate invested in?▸

Gate has invested in 1,203 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Gate invest in?▸

Gate's top investment sectors include Biotechnology, Health Care, Medical, Artificial Intelligence (AI), Therapeutics. The firm invests across 39 different industry categories.

What is Gate's largest investment?▸

Among tracked funding rounds, NILO Therapeutics received $101.0M in a Series A round. Gate's total known invested capital is $770.1M.

What is the average investment size for Gate?▸

Gate's average investment size is $8.3M across its portfolio of 1,203 companies.

What are Gate's most recent investments?▸

Recent Gate portfolio additions include Coherence Neuro, AUI (Augmented Intelligence), AltraTech, HumanTruths, Toragen. These companies were founded in 2020 or later.

Reach the founders behind these 1,203 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →